![]() |
|
|
Vol. 27, Issue 4, 502-509, April 1999
Department of Pharmacology, UCLA School of Medicine, Center for the Health Sciences, Los Angeles, California
| |
Abstract |
|---|
|
|
|---|
Organic nitrate esters, such as glyceryl trinitrate and isosorbide dinitrate, are a class of compounds used to treat a variety of vascular ailments. Their effectiveness relies on their ability to be bioactivated to nitric oxide (NO) which, in turn, relaxes vascular smooth muscle. Although there have been many biological studies that indicate that NO can be formed from organic nitrate esters in a biological environment, the chemical mechanism by which this occurs has yet to be established. Previous studies have implicated both flavins and thiols in organic nitrate ester bioactivation. Thus, we examined the chemical interactions of flavins and thiols with organic nitrate esters as a means of determining the role these species may play in NO production. Based on these studies we concluded that a reasonable chemical mechanism for organic nitrate ester bioactivation involves reduction to the organic nitrite ester followed by conversion to a nitrosothiol. The release of NO from nitrosothiols can occur via a variety of processes including reaction with dihydroflavins and NADH.
| |
Introduction |
|---|
|
|
|---|
Glyceryl trinitrate
(GTN),1
also referred to as nitroglycerin, was introduced over
100 years ago as a therapeutic agent for the treatment of angina
pectoris (Murrel, 1879
). Several other organic compounds with the
nitrate ester functional group
(-O-NO2) such as isosorbide dinitrate
and pentaerythritol tetranitrate, have similar pharmacological
properties and, like GTN, are often prescribed in the treatment of a
variety of heart and vascular ailments (Katzung and Chatterjee, 1989
).
Organic nitrate esters are characterized by their ability to relax
vascular smooth muscle and thus, lead to vasodilation and unloading of
the heart. Although the clinical effects of organic nitrate esters have
been known for over a century, the biochemical mechanism by which they
elicit smooth muscle relaxation became known only in the late 1970s. Organic nitrate esters are reductively metabolized to release nitric
oxide (NO) which, in turn, leads to the activation of guanylate cyclase, which catalyzes the conversion of GTP to cyclic GMP (Arnold et
al., 1977
; Ignarro et al., 1981a
; Kukovetz et al., 1979
). The increase
in cyclic GMP levels then leads to smooth muscle relaxation (for
reviews see Waldman and Murad, 1987
; Ignarro, 1989
; Schmidt et al.,
1993
; Murad, 1994
). Thus, the activity of organic nitrate esters is a
result of metabolism to NO (Chung and Fung, 1990
; Feelisch and Kelm,
1991
), which then can participate in the endogenous pathway by which
endothelial cells use NO to maintain vascular tone (Michel and Smith,
1993
). Although it is clear that reductive metabolism of organic
nitrate esters to NO is responsible for their biological activity, the
metabolic pathway and mechanism by which NO is generated from organic
nitrate esters have yet to be established.
One of the most troublesome aspects of organic nitrate ester therapy is
the fact that patients can become refractory to their effects. That is,
repeated and prolonged administration of organic nitrate esters results
in the development of tolerance. The development of tolerance is
characterized by a decrease in NO production. Interestingly, it has
also been found that a decrease in tissue thiol levels is associated
with the development of tolerance (Forster et al., 1991
; Needleman and
Johnson, 1973
). The fact that tolerance can be reversed with the
administration of thiol compounds (Torresi et al., 1985
) indicates a
critical role for thiols in the metabolism of organic nitrate esters to
NO (Elkayam, 1991
). Although there is a lack of conclusive data
defining the role of thiols in organic nitrate ester bioactivation,
S-nitrosothiols (RSNO compounds) have long been
implicated as possible intermediates in these processes (Ignarro et
al., 1981b
; Kurz et al., 1991
).
Previous studies indicate that the bioactivation of organic nitrate
esters to NO may be an enzymatic process, possibly involving the
cytochrome P-450 system (Servent et al., 1989
; Schroder, 1992
) and/or
the thiol requiring glutathione (GSH) S-transferase (Nigam et al., 1993
; Nigam et al., 1996
; Simon et al., 1996
). Moreover, it has
been reported that nitrate ester bioactivation can be mediated by a
flavoprotein (McGuire et al., 1994
). The implication that flavins and
thiols are involved in nitrate ester bioactivation prompted us to
examine the intimate chemistry between these species. Herein we report
that, indeed, flavin mononucleotide (FMN) is capable of catalyzing the
reduction of organic nitrate esters by NAD(P)H to reduced nitrogen
species, which may be precursors to NO formation. We further found that
thiols may participate in this chemistry and thus enhance the
generation of NO. This type of chemistry may serve as a basis for
understanding the role of both flavins and thiols in the bioactivation
of organic nitrate esters.
| |
Materials and Methods |
|---|
|
|
|---|
Materials and Solutions.
S-Nitroso-GSH (GSNO) was synthesized according to a
previously reported method (Hart, 1985
). GSH and n-butyl
nitrate were purchased from ICN Pharmaceuticals (Cleveland, OH). NADH
and n-butyl nitrite were purchased from Aldrich Chemical Co.
(Milwaukee, WI). Nitroglycerin was a generous gift from Zeneca
(Wilmington, DE). All solvents and reagents were obtained from
commercial sources and were of the highest purity available. Authentic
NO and N2O gas were purchased from Matheson Gas
Products (Cucamunga, CA). NO was passed through aqueous base before use
to trap any contaminating nitrogen oxides. All solutions, unless
specifically noted, were prepared in 100 mM, pH 7.4, potassium
phosphate buffer containing 5 mM desferrioxamine and adjusted back to
pH 7.4 with concentrated KOH or HCl. After the completion of reactions,
the pH of the resultant solutions was determined and found not to
differ by more than 0.2 pH units from the starting pH 7.4 in all cases.
Analytical Techniques. Analysis of n-butyl nitrate and n-butyl nitrite by HPLC. n-Butyl nitrate and n-butyl nitrite analysis was conducted on a Rainin HPLC system (Rainin Instrument Co., Woburn, MA) equipped with a 4.6 mm × 25 cm, 5-µm Beckman Ultrasphere reversed phase column (Beckman Instruments, Fullerton, CA), and a Spectra-Physics 100 UV-visible detector operating at 210 nm (Spectra-Physics Analytical, Mountain View, CA). The analytes were eluted using the following gradient: 0-7 min, 50% H2O/50% acetonitrile to 100% acetonitrile at a flow rate of 1.5 ml/min. The retention times for n-butyl nitrate and n-butyl nitrite were 5.5 min and 6.2 min, respectively. Quantitation was accomplished by comparison with standard curves prepared with authentic n-butyl nitrate and n-butyl nitrite.
Analysis of inorganic nitrite.
The method used in this study is a modification of a previously
published method (Green et al., 1982
).
N-(1-Naphthyl)-ethylenediamine solution (0.1%, w/v) was
prepared by the addition of 100 mg of N-(1-naphthyl)-ethylenediamine hydrochloride to 100 ml of
deionized water. A 1% (w/w) sulfanilamide solution was prepared by the
addition of 1 g of sulfanilamide to a 5%
H3PO4/distilled water
solution. Shortly before analysis, the assay solution consisting of an
equivolume mixture of both the 1%
N-(1-naphthyl)-ethylenediamine and 1% sulfanilamide solutions was prepared. A 200-µl aliquot (containing 20-200 nmol nitrite) of the sample to be analyzed was mixed with 1.8 ml of the
assay solution. The samples were heated at 60°C for 1 min and then
kept on ice. The absorbance at 546 nm of each sample was measured on a
Beckman DU-30 UV/Vis spectrophotometer. Comparisons of sample
absorbances to those obtained from Greiss reaction mixtures with known
nitrite concentrations were used for quantification.
NO detection.
Possible evolution of NO from reaction solutions was determined using a
method previously used in our laboratory (Wong et al., 1998
). Briefly,
through a 25-ml, three-neck flask equipped with a gas inlet adapter, a
gas outlet adapter, and a septum sealed inlet was passed argon through
a cold finger (0°C) and into an NO chemiluminescence detector (Antek
720 NO detector; Antek Instruments, Houston, TX). Analysis of gas
samples was accomplished by injection directly into the flask headspace
through the septum sealed inlet. Liquid samples or reaction solutions
were analyzed by simply sparging the solution with argon through a
Pasteur pipette attached to the gas inlet adapter.
N2O detection. Nitrous oxide detection and quantitation was performed on a 5710 Hewlett-Packard gas chromatograph (Hewlett-Packard Co., Palo Alto, CA) equipped with a thermal conductivity detector, 2-m × 9-mm Porapak Q column (Waters Associates, Inc., Framingham, MA) operating at 60°C, with a flow rate of 20 ml/min. Quantitation was achieved by comparison to a standard curve generated from samples of authentic N2O gas (Praxair, Rancho Cucamonga, CA) subjected to similar reaction conditions. Typical experimental N2O levels ranged between 0.1-5 µmol in a 100-µl injection. Retention time of N2O was 2.0 min.
Analysis for S-nitroso-t-butylthiol. S-Nitroso-t-butylthiol analysis was conducted on a Rainin HPLC system equipped with a 4.6 mm × 25 cm, 5-µm Beckman Ultrasphere reversed phase column and a Spectra-Physics 100 UV-visible detector operating at 210 nm. The analytes were eluted using the following gradient: 0-10 min, 50% H2O/50% acetonitrile to 100% acetonitrile at a flow rate of 1.5 ml/min. The retention times for benzaldhyde (internal standard) and S-nitroso-t-butylthiol were 2.8 min and 6.1 min, respectively. S-Nitroso-t-butylthiol was quantitated by comparison with standard curves prepared using authentic S-nitroso-t-butylthiol.
Experimental Procedures. Reaction of FMN with NADH and GSH to form dihydroflavin mononucleotide, fully reduced (FMNH2). Solutions of 300 µM FMN, 3 mM NADH, and 30 mM GSH in pH 7.4, 100 mM potassium phosphate buffer were prepared. Into three separate cuvettes, 1 ml of the FMN solution was added. The cuvettes were then filled with either 1 ml of the GSH solution and 1 ml buffer, 1 ml of the NADH solution and 1 ml buffer, or 1 ml each of the GSH and NADH. Total volume of each cuvette was 3 ml and the final concentrations of the added constituents were 100 µM FMN, 1 mM NADH and 10 mM GSH. The samples were deoxygenated on a vacuum line by several vacuum-nitrogen purge cycles. The absorbance spectra (250-500 nm) of the reaction solutions were then collected every 30 min.
Reaction of FMN/NADH (FMNH2) with NO and
GSNO.
Two samples each containing 1 ml each of 400 µM FMN and 4 mM NADH in
100 mM potassium phosphate buffer, pH 7.4, were placed into separate
quartz cuvettes and stoppered with rubber septa. The samples were
deoxygenated on a vacuum line by several vacuum-nitrogen purge cycles.
The samples were analyzed spectophotometrically from 500 to 250 nm
every 30 min. At 90 and 180 min, 100 µl of 1% GTN (44 mM) solution
were added to the samples. The absorbances at 445 nm
(
max for FMN) and 710 nm
(
max for NADH) were monitored. Quantitation of
FMN and NADH was then accomplished using a standard curve generated
from authentic solutions of FMN and NADH.
Reaction of FMN/NADH (FMNH2) with GTN.
Two samples, each containing 1 ml each of 200 µM FMN and 2 mM NADH in
100 mM potassium phosphate buffer, pH 7.4, were placed into separate
quartz cuvettes and stoppered with rubber septa. The samples were
deoxygenated on a vacuum line by several vacuum-nitrogen purge cycles.
The samples were analyzed spectophotometrically from 500 to 250 nm
every 30 min. At 90 min and 180 min, 100 µl of a 1% GTN (44 mM)
solution were added to samples 1 and 2, respectively. The absorbances
at 445 nm (
max for FMN) and 710 nm
(
max for NADH) were used to determine FMN and
NADH levels as described above.
Reaction of FMN/NADH (FMNH2) with NO and
GSNO.
Two samples, each containing 1 ml each of 400 µM FMN and 4 mM NADH in
pH 7.4, 100 mM potassium phosphate buffer were placed into separate
quartz cuvettes and stoppered with rubber septa. The samples were
deoxygenated on a vacuum line by several vacuum-nitrogen purge cycles.
The samples were analyzed spectophotometrically from 500 to 250 nm
every 10 min. At 60 min, successive amounts of 10 µl of pure
NO gas (0.4 µmol) were added to the samples. The absorbance at 445 nm
(
max for FMN) was used to determine FMN levels
using a standard curve of authentic FMN. The process was then repeated
using successive 50-µl aliquots of 2 mM GSNO.
Reaction of n-butyl nitrate with FMN, NADH, and GSH. Samples were prepared with either 200 µl of 75 mM FMN (15 µmol FMN), 100 µl of 200 mM (20 µmol) NADH, 1 ml of 200 mM GSH (100 µmol), or a combination of the reagents and diluted to 1.9 ml total volume with phosphate buffer solutions in 5 ml septum-stoppered, pear-shaped flasks. The samples were deoxygenated on a vacuum line by several vacuum-nitrogen purge cycles. Then, 100 µl of 100 mM (10 µmol) of n-butyl nitrate in acetonitrile was injected into each sample and allowed to react for 2 h. The samples were then analyzed for n-butyl nitrate and n-butyl nitrite by HPLC using the procedures described above.
Effect of NADH levels on n-butyl nitrate reduction. Samples were prepared with 200 µl of 75 mM FMN (15 µmol ) and 50, 100, or 250 µl of 200 mM (10, 20, or 50 µmol ) NADH and buffer for a total of 1.9 ml. The samples were deoxygenated on a vacuum line by several vacuum-nitrogen purge cycles. A 100-µl aliquot of a 100-mM (10 µmol ) n-butyl nitrate solution was then injected into each of the flasks. The samples were allowed to react for 2 h and then analyzed for n-butyl nitrate, n-butyl nitrite, inorganic nitrite, NO, and N2O using the methods listed above. The experiment was repeated with the addition of GSH (100 mM) to all of the reaction solutions.
Release of NO and N2O from reaction of n-butyl nitrate, n-butyl nitrite, and inorganic nitrite with FMN/NADH. Samples were prepared in 5-ml pear-shaped flasks equipped with glass stopcocks. Each flask contained 300 µl of 150 mM (45 µmol ) FMN, 1.5 ml of 100 mM (150 µmol ) NADH, and 1.1 ml of the potassium phosphate buffer, pH 7.4, solution (total volume 2.9 ml). The reaction vessels were then injected with 100 µl of 300-mM solutions of n-butyl nitrate in acetonitrile, n-butyl nitrite in acetonitrile, or sodium nitrite in buffer. The samples were allowed to react and headspace analyses for NO and N2O were conducted at 30, 90, 180, and 360 min and at 24 h.
Reaction of t-butylthiol with amylnitrite. Amyl nitrite (134 µl, 1 mmol) was dissolved in 10 ml acetonitrile and sparged with nitrogen to remove oxygen in a 25-ml septum-capped, foiled-covered Erlenmeyer flask. Then 113 µl of t-butyl thiol (1 mmol) was injected into the reaction vessel and the reagents were allowed to react for 3 h. HPLC analysis for S-nitroso-t-butyl thiol was carried out at as described above.
Release of NO from the reaction of GSNO with NADH/FMN. An aliquot containing 1 ml of 50 mM GSNO was injected into the NO detector reaction flask and NO evolution was monitored for 5 min. Then, 1 ml of 25 mM, 50 mM, or 100 mM NADH solution was injected into the flask and NO evolution was followed for an additional 15 min.
The release of NO from GSNO and NADH and FMN was also examined using a slightly different procedure: An aliquot containing 1 ml of 50 mM GSNO and 50 mM FMN was injected into the NO detector reaction flask and NO evolution was monitored for 5 min. Then, 1 ml of 25-mM solution of NADH was injected into the flask and NO evolution was followed for an additional 5 min.Release NO and N2O from reaction of GSNO with NADH/FMN-24 h reaction. Samples containing 300 µl of 100 mM FMN solution, 1.5 ml of 100 mM NADH, or both were placed into 5-ml pear-shaped flasks equipped with glass stopcocks. The volume was adjusted to 2.7 ml with additional buffer. The samples were deoxygenated on a vacuum line by several vacuum-nitrogen purge cycles. Then an aliquot containing 300 µl of a 100-mM GSNO solution that had been deoxygenated by vacuum was injected via syringe into each of the samples. The samples were allowed to mix for 24 h. Headspace analysis for NO and N2O was conducted using the methods described above.
Arterial smooth muscle relaxation.
The vasorelaxant activity of the model compounds used in this study was
evaluated using an arterial smooth muscle preparation previously
described (Fukuto et al., 1992
). Briefly, a 2.5- to 3.5-kg New Zealand
white male rabbit was sacrificed by lethal injection with pentobarbital
(~50 mg/kg). The thoracic aorta was carefully removed, cleared of fat
and connective tissue, and cut into 3-mm rings. The rings were then
mounted under 1 to 1.5 g of resting tension in 25-ml tissue baths
in Krebs-bicarbonate solution (pH 7.4) at 37°C and challenged with
phenylephrine. Changes in tension were measured isometrically on Grass
Polygraphs after administration of n-butyl nitrate and
n-butyl nitrite to the contracted tissues.
| |
Results and Discussion |
|---|
|
|
|---|
As mentioned previously, flavins have been implicated in the bioactivation of organic nitrate esters. This leads to the possibility that a reduced flavin species such as FMNH2 may be interacting with the organic nitrate ester substrate directly. Thus, the direct chemical interaction between FMNH2 and an organic nitrate ester was investigated.
Reaction of FMN with NADH, GSH and NADH + GSH.
Figure 1 shows the time-dependent
anaerobic reduction of FMN to FMNH2 by NADH as
measured by FMN loss. As expected, the FMN is reduced to the colorless
FMNH2 readily with the addition of excess (10 equivalents) NADH. This observation is in agreement with previous
chemical model studies that have shown a direct transfer of a hydride
from pyridine nucleotides to the flavin (Brustlein and Bruice, 1972
)
(reaction 1).
|
(1) |
|
(2) |
|
(3) |
|
Reaction of FMN with NADH and GTN. Figure 2 shows the conversion of FMN to FMNH2 by NADH as measured by loss of FMN. Additionally, the loss of NADH, due to its oxidation to NAD+, is shown in Fig. 3. With the addition of GTN at 90 and 180 min, FMNH2 was rapidly oxidized, as indicated by the reformation of FMN (Fig. 2). Also, NADH consumption in these experiments increased slightly upon the addition of GTN (Fig. 3). GTN alone was shown not to affect NADH levels (data not shown). Thus, these data indicate that FMNH2 is capable of reacting with GTN resulting in oxidation of FMNH2 to FMN and, presumably, GTN is subsequently reduced in the process. Similar results were seen upon addition of GSNO to the FMNH2 (data not shown). That is, GSNO was able to oxidize FMNH2 with subsequent reduction of GSNO (to be discussed later). Also, NO was capable of oxidizing FMNH2 as well (data not shown).
|
|
Reaction of n-butyl nitrate with FMN, NADH, and GSH.
Figure 4 shows the amount of
n-butyl nitrate remaining after its reaction with FMN, NADH,
GSH, or a combination the reagents. n-Butyl nitrate does not
appear to react with any of the reagents alone. However, its level
decreases greatly with the combination of FMN and NADH, indicating its
reaction with a reduced flavin species. GSH has no effect on
n-butyl nitrate levels except in the presence of both FMN
and NADH. The observation that n-butyl nitrate appears to
react only with a reduced flavin species formed from the
reaction of FMN and NADH, is similar to those seen in the reduction of
aryl-nitroso compounds by reduced flavins and pyridine nucleotides
(Leskovac et al., 1989
). In that particular study, the 2-electron
reduction of aryl-nitroso compounds to their corresponding
N-hydroxy analog was investigated. The ability of pyridine
nucleotides, such as NADH and reduced flavins, to perform this reaction
was compared and it was found that although both NADH and reduced
flavins were able to reduce the aryl-nitroso compounds, reduced flavins
were much more efficient reductants. Thus, our results are consistent
with these previous observations.
|
Product Analysis of FMN-Catalyzed Reduction of Organic Nitrate
Esters by NADH.
The reduction of organic nitrate esters can result in the generation of
a variety of products. For example, it is conceivable that nitrate
esters can be reduced by 2 electrons to form the corresponding nitrite
ester (reaction 4).
|
(4) |
1 s
1) under conditions
similar to those employed in these studies (Allen, 1952
|
(5) |
or
R-O-NO can lead to the formation of other reduced nitrogen species (mechanisms for these possibilities will be discussed later).
Thus, to examine the possibility that reactions 4 and 5 (and others)
were occurring, the products of the FMN-catalyzed reduction of the
organic nitrate ester by NADH were examined. Thus, reactions were
analyzed for formation of NO, N2O,
R-O-NO, and NO2
.
Also, the effect of reducing agent (NADH) equivalents on the formation
of these products was determined. Figure
5 graphically depicts the results. It
appears that increasing amounts of NADH leads to both increasing loss
of n-butyl nitrate and the formation of inorganic nitrite.
Interestingly, inorganic nitrate
(NO3
) and n-butyl
nitrite were not detected. Moreover, NO levels were less than 1% of
the starting n-butyl nitrate. At a high NADH/organic nitrate
ester ratio, a small but significant amount of
N2O was formed. The effect of GSH on product
formation from the FMN-catalyzed reduction of the organic nitrate ester
by NADH was determined (Fig. 6). GSH
clearly enhanced the formation of the reduction products
NO2
and
N2O compared with reactions performed in the
absence of the thiol (Fig. 5).
|
|
|
(6) |
ON(+3)O), it is possible
that HNO could have formed as a result of reduction of any three of
these species, R-O-NO2,
R-O-NO, or NO2
.
Therefore, the generation of HNO (as detected by
N2O formation) was examined from reactions of all
of these species. Also, possible NO generation was monitored as well.
Formation of NO and N2O by Reaction of
n-Butyl Nitrate, n-Butyl Nitrite, and
Inorganic Nitrite with FMN/NADH.
n-Butyl nitrate, n-butyl nitrite, and inorganic
nitrite were reacted separately with both FMN and NADH. Headspace
analysis was conducted at various time points to determine NO and
N2O production. NO levels in all three samples
were fairly low (<%1) and decreased over time (data not shown).
N2O levels (Fig.
7), however, increased slowly with
inorganic nitrite releasing the greatest amount of N2O. This observation is consistent with the idea
that N2O is formed from the reduction of
inorganic nitrite by FMNH2. Thus, a plausible
pathway for the generation of HNO in these systems is indicated in
Scheme 1. One- electron reduction
of the nitrate ester generates the nitroxide intermediate, which
undergoes further 1-electron reduction to give a hydrated nitrite
ester, which loses water to give the nitrite ester. Hydrolysis of the
nitrite ester generates NO2
,
which is then subject to further 2-electron reduction to HNO.
|
|
Reaction of t-Butylthiol with Amyl Nitrite.
Herein, we have found that thiols (i.e., GSH) can enhance the reduction
of organic nitrate esters, possibly by assisting in the generation of
the FMNH2. However, this clearly is not the only
effect thiols can have in these reaction systems. Previous labs have
proposed that thiols such as GSH may react with organic nitrite esters
to the corresponding S-nitrosothiol which, in turn, serves
as a precursor to NO formation (reaction 7) (Meyer et al., 1994
;
Ji et al., 1996
).
|
(7) |
|
Formation of NO from Reaction of GSNO with FMN/NADH.
Figure 8 shows the release of NO from GSNO
upon the addition of NADH. NO release is proportional to the amount of
NADH added. The presence of FMN in this system greatly enhances NO
release. NO may be generated by two different mechanisms. When only
NADH is present, the hydride from the pyridine nucleotide reacts with the S-nitrosothiol to afford a free thiol and HNO (reaction
8).
|
(8) |
|
(9) |
|
(10) |
|
(11) |
|
(12) |
|
Formation of NO and N2O from Reaction GSNO with FMN and
NADH (24 h).
Figure 9 shows the formation of NO and
N2O from the reaction of GSNO with NADH, FMN, or
both NADH and FMN. Appreciable amounts of NO release occur only during
the reaction between GSNO and NADH. N2O is formed
when GSNO is reacted with both NADH and FMN. The explanation for this
result may involve not only the ability of reduced flavin species to
reduce GSNO to NO (reactions 10 and 11) but also their ability to
reduce NO even further according to reaction (13 and 14).
|
(13) |
|
(14) |
|
Biological Activity of n-Butyl Nitrate and
n-Butyl Nitrite.
Most clinically used organic nitrate esters (i.e., GTN, isosorbide
dinitrate, etc.) contain multiple nitrate ester functions. Because the
model compounds used in this study contain only one nitrate ester
function, there is the possibility that significant physiological
NO release requires multiple nitrate esters on the same molecule.
Therefore, to address this issue and test the feasibility of
n-butyl nitrate as an appropriate model compound, the
ability of n-butyl nitrate and its organic nitrite ester
analog, n-butyl nitrite, to elicit vasodilation in smooth
muscle tissue was examined. In rabbit aorta challenged with
phenylephrine, both n-butyl nitrate and n-butyl
nitrite elicited vasorelaxation. The EC50s of the compounds were 2.2 × 10
5 and 7.8 × 10
6 M, respectively. The biological assays with
n-butyl nitrate and n-butyl nitrite indicate that
both compounds do have vasodilatory properties, albeit not as potent as
GTN itself (Kowaluk and Fung, 1991
). The n-butyl nitrite
ester used in our study does show increased potency over that of the
nitrate, however, the difference is not as dramatic as seen in previous
studies (Zimmermann et al., 1991
). Nevertheless, the increased potency
of the nitrite ester versus that of the nitrate ester is consistent
with a possible role of the nitrite ester as an intermediate in
bioactivation of organic nitrate esters.
Summary.
Through the use of biological reducing agents, this study was able to
determine a possible mechanism by which organic nitrate esters can be
bioactivated to NO. Organic nitrate esters are readily reduced to
organic nitrite esters in the presence of a reduced flavin species. GSH
can then react with the organic nitrite ester to form an
S-nitrosothiol, which has been shown to release NO through a
variety of mechanisms. This chemical hypothesis thus reconciles
previous studies that have implicated both flavoproteins and thiols in
the bioactivation of organic nitrate esters to NO. It should be
emphasized that the metabolic pathway described herein for the
generation of NO from organic nitrate esters is likely to be only a
minor physiological event. That is, the major metabolic fate of organic
nitrate esters in not via pathways that will easily evolve NO but
rather pathways that generate, for example,
NO3
. However, because NO is an
extremely potent vasorelaxant, even low metabolic yields of NO from
organic nitrate esters allows these compounds to be therapeutically viable.
| |
Footnotes |
|---|
Received September 14, 1998; accepted January 6, 1999.
Send reprint requests to: Jon M. Fukuto, Department of Pharmacology, UCLA School of Medicine, Center for the Health Sciences, Los Angeles, CA 90095-1735. E-mail: jon{at}pharm.mednet.ucla.edu
| |
Abbreviations |
|---|
Abbreviations used are: FMN, flavin mononucleotide, fully oxidized; FMNH2, dihydroflavin mononucleotide, fully reduced; GSH, glutathione; GSNO, S-nitroso-GSH; GTN, glyceryl trinitrate/nitroglycerin; NO, nitric oxide; HNO, nitroxyl.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Katayama, K. Nakajou, H. Komori, K. Uchida, J.-i. Yokoe, N. Yasui, H. Yamamoto, T. Kai, M. Sato, T. Nakagawa, et al. Design and Evaluation of S-Nitrosylated Human Serum Albumin as a Novel Anticancer Drug J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, X. Liu, H. Cui, Y.-R. Chen, A. J. Cardounel, and J. L. Zweier Characterization of the Mechanism of Cytochrome P450 Reductase-Cytochrome P450-mediated Nitric Oxide and Nitrosothiol Generation from Organic Nitrates J. Biol. Chem., May 5, 2006; 281(18): 12546 - 12554. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, H. Cui, X. Liu, and J. L. Zweier Xanthine Oxidase Catalyzes Anaerobic Transformation of Organic Nitrates to Nitric Oxide and Nitrosothiols: CHARACTERIZATION OF THIS MECHANISM AND THE LINK BETWEEN ORGANIC NITRATE AND GUANYLYL CYCLASE ACTIVATION J. Biol. Chem., April 29, 2005; 280(17): 16594 - 16600. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Janero, N. S. Bryan, F. Saijo, V. Dhawan, D. J. Schwalb, M. C. Warren, and M. Feelisch Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo PNAS, November 30, 2004; 101(48): 16958 - 16963. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||